Category: Pharmaceuticals
Pharmaceuticals market research reports by DelveInsight
-
Smoking Cessation- Pipeline Insight, 2024
Smoking Cessation- Pipeline Insight, 2024 DelveInsight’s, “Smoking Cessation- Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Smoking Cessation pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical st ... Read More
-
Lupus Nephritis - Pipeline Insight, 2024
Lupus Nephritis - Pipeline Insight, 2024 DelveInsight’s, “Lupus Nephritis - Pipeline Insight, 2024” report provides comprehensive insights about 30+ companies and 35+ pipeline drugs in Lupus Nephritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More
-
Acute Coronary Syndrome - Market Insight, Epidemiology And Market Forecast - 2034
Acute Coronary Syndrome - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights According to DelveInsight’s estimates, in 2023, there were approximately 1,028,651 diagnosed prevalent cases of NCFB in the 7MM. Of these, the US accounted for approximately 37% of the cases, EU4 and the ... Read More
-
Bronchiectasis - Market Insight, Epidemiology And Market Forecast - 2034
Bronchiectasis - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Chronic Obstructive Pulmonary Disease (COPD) market was valued at USD 16,075 million in 2023 and is expected to experience consistent growth during the forecast period (2024–2034). This growth is primarily d ... Read More
-
Chronic Heart Failure - Market Insight, Epidemiology And Market Forecast - 2034
Chronic Heart Failure - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the market size of Atherosclerotic Cardiovascular Disease (ASCVD) was highest in the US among the 7MM, accounting for approximately USD 12 billion which is further expected to rise at a CAGR of 2. ... Read More
-
Eosinophilic Esophagitis - Market Insight, Epidemiology And Market Forecast - 2034
Eosinophilic Esophagitis - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The total market size in the 7MM for ITP was estimated to be nearly USD 4,100 million in 2023, which is expected to grow with a significant CAGR during the forecast period. In 2023, the US accounted for ... Read More
-
Mild Cognitive Impairment - Market Insight, Epidemiology And Market Forecast - 2034
Mild Cognitive Impairment - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Parainfluenza virus infection market is projected to witness consistent growth throughout the forecast period (2024–2034). The market size of parainfluenza virus infection in the 7MM is expected to ... Read More
-
Parkinson's Disease Market Insight, Epidemiology And Market Forecast - 2034
Parkinson's Disease Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Parkinson’s disease Psychosis (PDP) market is projected to witness consistent growth throughout the forecast period (2024–2034). The market size of PDP in the 7MM is expected to increase, driven by better ... Read More
-
Lupus Nephritis - Market Insight, Epidemiology And Market Forecast - 2034
Lupus Nephritis - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights According to the IgA Nephropathy Foundation, IgA nephropathy is an autoimmune disease that attacks the kidneys and affects blood filtration in the kidneys' small blood vessels. IgA nephropathy occurs when an abn ... Read More
-
Myotonic Dystrophy - Epidemiology Forecast - 2034
Myotonic Dystrophy - Epidemiology Forecast - 2034 Key Highlights DelveInsight's analysis indicates that there were nearly 54,068 diagnosed prevalent cases of myotonic dystrophy in the United States in 2023. Projections suggest that these cases will continue to rise, with anticipated growth reaching ... Read More
-
Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2034
Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Down’s syndrome is a genetic condition caused by an error in cell division called ""nondisjunction,"" resulting in an individual having a full or partial extra copy of chromosome 2 ... Read More
-
Mild Cognitive Impairment - Epidemiology Forecast - 2034
Mild Cognitive Impairment - Epidemiology Forecast - 2034 Key Highlights In 2023, the total diagnosed prevalence of MCI in Parkinson’s disease was highest in Germany among the EU4 and the UK, accounting for nearly 995 thousand cases which is further expected to increase by 2034. In the US, in 2023, ~ ... Read More
-
Myotonic Dystrophy Market Insight, Epidemiology And Market Forecast - 2034
Myotonic Dystrophy Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights According to DelveInsight’s estimates, in 2023, there were approximately 2,718 thousand diagnosed prevalent cases of Parkinson’s disease in the 7MM. Of these, the United States accounted for 45% of the cases, w ... Read More
-
Complement 3 Glomerulopathy Market Insight, Epidemiology And Market Forecast - 2034
Complement 3 Glomerulopathy Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Diamond-Blackfan anemia (DBA) is a rare genetic disorder that primarily affects the bone marrow's ability to produce red blood cells, leading to severe anemia. It is usually diagnosed in infancy or ear ... Read More
-
Parkinson's Disease Psychosis Market Insight, Epidemiology And Market Forecast - 2034
Parkinson's Disease Psychosis Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the market size of Mild Cognitive Impairment (MCI) was highest in the US among the 7MM, accounting for approximately USD 1,467 million which is further expected to increase by 2034. In 2023, ... Read More
-
Primary Sclerosing Cholangitis (PSC) - Market Insight, Epidemiology And Market Forecast - 2034
Primary Sclerosing Cholangitis (PSC) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Osteogenesis Imperfecta (OI) is a group of genetic disorders that mainly affect the development of bones. People with this condition have bones that break easily, often from little or no tra ... Read More
-
Alzheimer's Disease Market Insight, Epidemiology And Market Forecast - 2034
Alzheimer's Disease Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Myotonic Dystrophy market is projected to witness consistent growth throughout the forecast period (2024–2034). The market size of Myotonic Dystrophy in the 7MM is expected to increase, driven by better di ... Read More
-
Chronic Obstructive Pulmonary Disease (COPD) - Epidemiology Forecast - 2034
Chronic Obstructive Pulmonary Disease (COPD) - Epidemiology Forecast - 2034 Key Highlights DelveInsight’s analyst projects that the Total Diagnosed Prevalent Cases of Chronic Obstructive Pulmonary Disease (COPD) in the 7MM were ~33.3 million in 2023 and these cases are going to increase during the f ... Read More
-
Neuroendocrine Tumors - Market Insight, Epidemiology And Market Forecast - 2034
Neuroendocrine Tumors - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights C3 glomerulopathy (C3G) is a rare kidney disorder characterized by the abnormal buildup of the complement protein C3 in the glomeruli, the filtering units of the kidneys. This excessive complement activati ... Read More
-
Pharmaceutical Excipients - Market Insights, Competitive Landscape, and Market Forecast - 2030
Pharmaceutical Excipients - Market Insights, Competitive Landscape, and Market Forecast - 2030 Pharmaceutical Excipients Market by Type (Organic Chemicals, Inorganic Chemicals, and Others), Application (Oral, Parenteral, and Topical), Functionality (Fillers, Binders, Coatings and Colorants, Flavouri ... Read More
-
Gastric Cancer Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030
Gastric Cancer Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030 Gastric Cancer Diagnostics Market by Product Type (Instruments, Reagents & Kits), Test Type (Imaging Test [Upper Endoscopy, Barium Swallow/X-Rays, CT Scan, Laparoscopy, MRI, Stomach Ultrasound, and Others ... Read More
-
Multiple Sclerosis - Pipeline Insight, 2024
Multiple Sclerosis - Pipeline Insight, 2024 DelveInsight’s, “Multiple Sclerosis - Pipeline Insight, 2024” report provides comprehensive insights about 80+ companies and 85+ pipeline drugs in Multiple Sclerosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinic ... Read More
-
Etanercept – Biosimilar Insight, 2024
Etanercept – Biosimilar Insight, 2024 DelveInsight’s, “Etanercept – Biosimilar Insight, 2024” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Etanercept pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. I ... Read More
-
Sepsis- Pipeline Insight, 2024
Sepsis- Pipeline Insight, 2024 DelveInsight’s, “Sepsis- Pipeline Insight, 2024” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Sepsis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the ... Read More
-
Wet Age-Related Macular Degeneration (Wet AMD) - Pipeline Insight, 2024
Wet Age-Related Macular Degeneration (Wet AMD) - Pipeline Insight, 2024 DelveInsight’s, “Wet Age-Related Macular Degeneration (Wet AMD) - Pipeline Insight, 2024” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Wet Age-Related Macular Degeneration (Wet AMD) pipeli ... Read More
Research Assistance
